卫生部长罗伯特·肯尼迪(Robert F. Kennedy Jr.)呼吁对堕胎药丸Mifeprístone进行安全审查, Health Secretary Robert F. Kennedy Jr. calls for a safety review of the abortion pill mifepristone amid conflicting claims.

美国卫生与公众服务秘书罗伯特·肯尼迪(Robert F. Kennedy Jr.)要求对Mifepristone进行安全审查,Mifepristone是美国食品与药物管理局2000年批准的堕胎药丸。 Robert F. Kennedy Jr., the U.S. Health and Human Services Secretary, has requested a safety review of mifepristone, an abortion pill approved by the FDA in 2000. 该请求是在报告声称每10名病人中就有1人发生严重不利事件之后提出的,尽管卫生专家认为这些指称具有误导性。 The request follows a report claiming serious adverse events in 1 in 10 patients, though health experts argue these claims are misleading. 自该药物获得批准以来,已有500多万人使用该药物。 More than 5 million people have used the drug since its approval. 与此同时,来自四个州的总检察长已请求林业发展局取消对mifepristone的限制,声称尽管有安全记录,但在初级保健环境中很难开药。 Meanwhile, attorneys general from four states have petitioned the FDA to lift restrictions on mifepristone, arguing they make it difficult to prescribe the drug in primary care settings, despite its safety record.